ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1853

Each Joint in a 28 Joint Count Is More Likely to Be Affected by Deformity/Limited Motion Than by Swelling in Rheumatoid Arthritis Patients with Long Disease Duration: Deformity/Limited Motion Should Be Included in Joint Counts Performed in Routine Care

Rahel Hunter1, Nicholas Rodwell2 and Theodore Pincus1, 1Rush University Medical Center, Chicago, IL, 2Liverpool Hospital, Liverpool, Australia

Meeting: ACR Convergence 2023

Keywords: Outcome measures, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1840–1861) Health Services Research Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The 28 joint count for rheumatoid arthritis (RA) was designed to recognize 3 abnormalities: swelling, (SWL), tenderness/pain on motion (TEN), and deformity/limited motion (DEF), recorded as total swollen joint count (SJC), tender/pain on motion joint count (TJC), and deformed/limited motion joint count (DJC). In clinical trials over 6-12 months, DJC generally is omitted, appropriately, as the aim is to assess reduction of inflammation by active vs control treatments in groups of selected patients. However, omission of DJC has been extended to most long-term routine care and longitudinal databases, potentially underestimating the severity of patient status. We compared the likelihood of SWL, TEN and DEF in individual joints in 28 joint counts which were assessed in RA patients who had been treated over long periods.

Methods: A standard 28 joint count was performed at a routine care visit of 104 RA patients who had been treated over long periods, in which SWL, TEN and DEF were recorded for each joint. The total SJC, TJC, and DJC was recorded as totals of SWL, TEN and DEF in each of the 28 joints. The numbers of SWL, TEN and DEF of wrists, elbows, shoulders and knees were calculated for individual joints. Median values for 5 each of left (L) and right (R) interphalangeal (PIP) joints and metacarpophalangeal joints (MCP) were calculated to represent these joints.

Results: The study included 104 patients with mean and median age of 59.9 and 61.3 years and mean and median disease duration of 11.6 and 10.0 years, respectively. The mean and median total SJC was 1.8 and 0, TJC 3.9 and 2, and DJC 5.5 and 4, respectively (Table). The highest levels for all joint abnormalities were seen in wrists and lowest in elbows, although differences were not large. DEF was higher than SWL for all joints and joint groups included in the 28 joint count (Table). DEF was also higher than TEN for all 20 PIP and MCP joints (only 4 medians are included in the table) and wrists; TEN was marginally higher than DEF for shoulder, elbow, and knee joints.

Conclusion: Patients treated in the biological era with median disease duration of 10 years have low total SJC, reflecting excellent control of inflammation. However, joint deformity (and tenderness) are considerably more prevalent than swelling. Omission of deformity/limited motion, as is appropriately usual in clinical trials, in long-term care and longitudinal databases may give inappropriately favorable impressions of long-term RA outcomes. It is suggested that DJC be included in all formal joint counts in routine clinical care and long-term databases.

Supporting image 1

Number of patients (total=104) with involvement of specific joints or joint groups included in the 28 joint count with swelling (SJC), tenderness/pain on motion (TJC), and/or deformity/limited motion (DJC)
Highest total in bold
*=Median of 5 joints


Disclosures: R. Hunter: None; N. Rodwell: None; T. Pincus: None.

To cite this abstract in AMA style:

Hunter R, Rodwell N, Pincus T. Each Joint in a 28 Joint Count Is More Likely to Be Affected by Deformity/Limited Motion Than by Swelling in Rheumatoid Arthritis Patients with Long Disease Duration: Deformity/Limited Motion Should Be Included in Joint Counts Performed in Routine Care [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/each-joint-in-a-28-joint-count-is-more-likely-to-be-affected-by-deformity-limited-motion-than-by-swelling-in-rheumatoid-arthritis-patients-with-long-disease-duration-deformity-limited-motion-should-b/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/each-joint-in-a-28-joint-count-is-more-likely-to-be-affected-by-deformity-limited-motion-than-by-swelling-in-rheumatoid-arthritis-patients-with-long-disease-duration-deformity-limited-motion-should-b/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology